
Desotop15 gm
ACI Limited
Desonide is a low-potency (Class VI) topical corticosteroid used for the relief of inflammation and pruritus (itching) associated with corticosteroid-responsive skin conditions.
Desonide is a low-potency (Class VI) topical corticosteroid used for the relief of inflammation and pruritus (itching) associated with corticosteroid-responsive skin conditions.
Desonide is intended for short-term, intermittent use on limited body surface areas rather than as a continuous long-term therapy.
| Formulation | Frequency | Maximum duration |
|---|---|---|
| Cream / ointment / lotion 0.05% | Apply a thin film to the affected area 2 to 4 times daily | Up to 2 weeks, unless a physician directs otherwise |
| Gel / foam 0.05% | Apply a thin film to the affected area twice daily | Up to 4 weeks, unless a physician directs otherwise |
| Age group | Guidance |
|---|---|
| 3 months and older | Desonide cream, ointment, lotion, gel, or foam (0.05%) may be used as directed by a physician, applying the minimum amount needed for the shortest effective duration |
| Below 3 months | Safety and efficacy of Desonide have not been established; use is not recommended |
Treatment should be reassessed by a physician if there is no improvement within 2 to 4 weeks, or sooner if the condition worsens.
Patients should discontinue Desonide and seek medical advice if the treated condition worsens or if signs of infection or systemic effects develop.
Desonide is contraindicated in:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.